论文部分内容阅读
目的对肝动脉化疗栓塞与伽玛刀序贯联合疗法在中晚期肝细胞癌患者治疗中的临床应用价值进行探讨。方法 74例中晚期肝细胞癌患者,随机分为观察组(38例)和对照组(36例),对照组患者仅采取肝动脉化疗栓塞治疗,观察组患者采取肝动脉化疗栓塞与伽玛刀序贯联合疗法治疗。观察并比较两组的临床疗效。结果观察组患者的甲胎蛋白水平降低例数明显多于对照组,差异具有统计学意义(P<0.05);观察组患者的总有效率显著高于对照组,差异具有统计学意义(P<0.05);观察组患者的生存率高于对照组,差异具有统计学意义(P<0.05)。结论治疗中晚期肝细胞癌患者采取肝动脉化疗栓塞与伽玛刀序贯联合疗法,能够明显提高患者预后质量,增强治疗效果,延长生存期限。
Objective To investigate the clinical value of hepatic arterial chemoembolization and gamma knife sequential combined therapy in the treatment of patients with advanced hepatocellular carcinoma. Methods Totally 74 patients with advanced hepatocellular carcinoma were randomly divided into observation group (n = 38) and control group (n = 36). Patients in the control group received hepatic arterial chemoembolization only. Patients in the observation group received hepatic arterial chemoembolization and gamma knife Sequential combination therapy. Observed and compared the clinical efficacy of the two groups. Results The number of AFP decreased in the observation group was significantly higher than that in the control group (P <0.05). The total effective rate in the observation group was significantly higher than that in the control group (P < 0.05). The survival rate of observation group was higher than that of control group, the difference was statistically significant (P <0.05). Conclusion The treatment of advanced hepatocellular carcinoma in patients with hepatic artery chemoembolization and gamma knife sequential combination therapy can significantly improve the prognosis of patients with quality and enhance the therapeutic effect and prolong survival.